Shuang G Zhao1, Neil B Alexander2,3, Zora Djuric4, Jessica Zhou1, Yebin Tao5, Matthew Schipper1,5, Felix Y Feng1, Avraham Eisbruch1, Francis P Worden6, Scott J Strath7, Shruti Jolly1,8. 1. Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. 2. Division of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. 3. Geriatrics Research, Education and Clinical Center, University of Michigan, Ann Arbor, Michigan. 4. Department of Family Medicine, University of Michigan, Ann Arbor, Michigan. 5. Department of Biostatistics, University of Michigan, Ann Arbor, Michigan. 6. Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. 7. Department of Kinesiology, Center for Aging and Translational Research, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin. 8. Department of Radiation Oncology, Veterans Affairs Ann Arbor Health Care System, Ann Arbor, Michigan.
Abstract
BACKGROUND:Concurrent chemoradiotherapy (concurrent CRT) to treat head and neck cancer is associated with significant reductions of weight, mobility, and quality of life (QOL). An intervention focusing on functional exercise may attenuate these losses. METHODS: We allocated patients to a 14-week functional resistance and walking program designed to maintain physical activity during cancer treatment (MPACT group; n = 11), or to usual care (control group; n = 9). Outcomes were assessed at baseline, and 7 and 14 weeks. RESULTS: Compared to controls, the MPACT participants had attenuated decline or improvement in several strength, mobility, physical activity, diet, and QOL endpoints. These trends were statistically significant (p < .05) in knee strength, mental health, head and neck QOL, and barriers to exercise. CONCLUSION: In this pilot study of patients with head and neck cancer undergoing concurrentCRT, MPACT training was feasible and maintained or improved function and QOL, thereby providing the basis for larger future interventions with longer follow-up.
RCT Entities:
BACKGROUND: Concurrent chemoradiotherapy (concurrent CRT) to treat head and neck cancer is associated with significant reductions of weight, mobility, and quality of life (QOL). An intervention focusing on functional exercise may attenuate these losses. METHODS: We allocated patients to a 14-week functional resistance and walking program designed to maintain physical activity during cancer treatment (MPACT group; n = 11), or to usual care (control group; n = 9). Outcomes were assessed at baseline, and 7 and 14 weeks. RESULTS: Compared to controls, the MPACTparticipants had attenuated decline or improvement in several strength, mobility, physical activity, diet, and QOL endpoints. These trends were statistically significant (p < .05) in knee strength, mental health, head and neck QOL, and barriers to exercise. CONCLUSION: In this pilot study of patients with head and neck cancer undergoing concurrent CRT, MPACT training was feasible and maintained or improved function and QOL, thereby providing the basis for larger future interventions with longer follow-up.
Authors: Joseph A Roscoe; Maralyn E Kaufman; Sara E Matteson-Rusby; Oxana G Palesh; Julie L Ryan; Sadhna Kohli; Michael L Perlis; Gary R Morrow Journal: Oncologist Date: 2007
Authors: Laura Q Rogers; Philip M Anton; Amanda Fogleman; Patricia Hopkins-Price; Steven Verhulst; Krishna Rao; James Malone; Randy Robbs; Kerry S Courneya; Parashar Nanavati; Sara Mansfield; K Thomas Robbins Journal: Head Neck Date: 2012-07-30 Impact factor: 3.147
Authors: Richard P Troiano; David Berrigan; Kevin W Dodd; Louise C Mâsse; Timothy Tilert; Margaret McDowell Journal: Med Sci Sports Exerc Date: 2008-01 Impact factor: 5.411
Authors: Sonia A Duffy; Theodoros Teknos; Jeremy M G Taylor; Karen E Fowler; Mozaffarul Islam; Gregory T Wolf; Scott McLean; Tamer A Ghanem; Jeffrey E Terrell Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-01-08 Impact factor: 4.254
Authors: Lauren C Capozzi; Harold Lau; Raylene A Reimer; Margaret McNeely; Janine Giese-Davis; S Nicole Culos-Reed Journal: BMC Cancer Date: 2012-10-02 Impact factor: 4.430
Authors: Mary Jarden; Tom Møller; Lars Kjeldsen; Henrik Birgens; Jesper Frank Christensen; Karl Bang Christensen; Finn Diderichsen; Carsten Hendriksen; Lis Adamsen Journal: BMC Cancer Date: 2013-10-02 Impact factor: 4.430
Authors: Heidi Mason; Mary Beth DeRubeis; Nancy Burke; Melissa Shannon; Danielle Karsies; Gregory Wolf; Avi Eisbruch; Francis Worden Journal: World J Clin Oncol Date: 2016-04-10
Authors: Moira A Visovatti; Mi Sook Jung; Heidi Mason; Mary Beth DeRubeis; Francis P Worden; Debra L Barton Journal: Cancer Nurs Date: 2022-01-12 Impact factor: 2.760
Authors: Camilla K Lonkvist; Simon Lønbro; Anders Vinther; Bo Zerahn; Eva Rosenbom; Hanne Primdahl; Pernille Hojman; Julie Gehl Journal: BMC Cancer Date: 2017-06-03 Impact factor: 4.430
Authors: Camilla K Lonkvist; Anders Vinther; Bo Zerahn; Eva Rosenbom; Atul S Deshmukh; Pernille Hojman; Julie Gehl Journal: Laryngoscope Investig Otolaryngol Date: 2017-07-19
Authors: Rebecca R Turner; Liz Steed; Helen Quirk; Rosa U Greasley; John M Saxton; Stephanie Jc Taylor; Derek J Rosario; Mohamed A Thaha; Liam Bourke Journal: Cochrane Database Syst Rev Date: 2018-09-19
Authors: Laurien M Buffart; Remco de Bree; Martine Altena; Sophie van der Werff; Constance H C Drossaert; Caroline M Speksnijder; Michiel W van den Brekel; Harriët Jager-Wittenaar; Neil K Aaronson; Martijn M Stuiver Journal: Support Care Cancer Date: 2017-11-18 Impact factor: 3.603